Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Humira Efficacy Response Optimization Study in Subjects With Active Rheumatoid Arthritis (HERO)

NCT00234897 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00234897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00234897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Humira Efficacy Response Optimization Study in Subjects With Active Rheumatoid Arthritis (HERO)
Lead sponsor
Abbott
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2004
Completion date
Not reported
Enrollment
1,938 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis